Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

The promise of selective MET inhibitors in non-small cell lung cancer with MET exon 14 skipping.

Salgia R, Sattler M, Scheele J, Stroh C, Felip E. The promise of selective MET inhibitors in non-small cell lung cancer with MET exon 14 skipping. Cancer Treat Rev. 2020 Jul; 87:102022.

View in: PubMed

collapse authors with profiles